Acutus Medical, Inc.
AFIB
$0.0302
-$0.0106-25.98%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.13M | 5.27M | 4.13M | 3.63M | 2.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.13M | 5.27M | 4.13M | 3.63M | 2.35M |
| Cost of Revenue | 6.13M | 4.89M | 4.47M | 3.66M | 2.47M |
| Gross Profit | 1.01M | 372.00K | -343.00K | -30.00K | -118.00K |
| SG&A Expenses | 2.56M | 2.32M | 2.23M | 3.34M | 4.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.68M | 7.21M | 6.70M | 6.99M | 7.76M |
| Operating Income | -1.55M | -1.95M | -2.57M | -3.37M | -5.41M |
| Income Before Tax | -1.31M | -816.00K | -362.00K | -2.06M | -1.98M |
| Income Tax Expenses | -- | -- | -- | -- | 63.00K |
| Earnings from Continuing Operations | -1.31M | -816.00K | -362.00K | -2.06M | -2.04M |
| Earnings from Discontinued Operations | -95.00K | -4.79M | -552.00K | 435.00K | -31.72M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.41M | -5.61M | -914.00K | -1.62M | -33.77M |
| EBIT | -1.55M | -1.95M | -2.57M | -3.37M | -5.41M |
| EBITDA | -1.49M | -1.87M | -2.49M | -3.28M | -5.36M |
| EPS Basic | -0.05 | -0.19 | -0.03 | -0.05 | -1.15 |
| Normalized Basic EPS | -0.05 | -0.07 | -0.07 | -0.10 | -0.11 |
| EPS Diluted | -0.05 | -0.19 | -0.03 | -0.05 | -1.15 |
| Normalized Diluted EPS | -0.05 | -0.07 | -0.07 | -0.10 | -0.11 |
| Average Basic Shares Outstanding | 29.77M | 29.80M | 29.72M | 29.69M | 29.31M |
| Average Diluted Shares Outstanding | 29.77M | 29.80M | 29.72M | 29.69M | 29.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |